This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
CA Altar , RE Whitehead , G Chen , G Wörtwein , TM Madsen (2003). Effects of electroconvulsive seizures and antidepressant drugs on brain-derived neurotrophic factor protein in rat brain. Biological Psychiatry 54, 703–709.
S Anttila , K Huuhka , M Huuhka , R Rontu , M Hurme , E Leinonen , T Lehtimäki (2007). Interaction between 5-HT1A and BDNF genotypes increases the risk of treatment-resistant depression. Journal of Neural Transmission 114, 1065–1068.
BT Baune , C Hohoff , K Berger , A Neumann , S Mortensen , T Roehrs , J Deckert , V Arolt , K Domschke (2008 a). Association of the COMT val158met variant with antidepressant treatment response in major depression. Neuropsychopharmacology 33, 924–932.
BT Baune , C Hohoff , T Roehrs , J Deckert , V Arolt , K Domschke (2008 b). Serotonin receptor 1A -1019C/G variant: impact on antidepressant pharmacoresponse in melancholic depression? Neuroscience Letters 436, 111–115.
B Chen , D Dowlatshahi , GM MacQueen , JF Wang , LT Young (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 50, 260–265.
L Chen , D Lawlor , S Lewis , W Yuan , M Abdollahi , N Timpson , I Day , S Ebrahim , G Smith , Y Shugart (2008). Genetic association study of BDNF in depression: finding from two cohort studies and a meta-analysis. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 147B, 814–821.
M Choi , R Kang , S Lim , K Oh , M Lee (2006). Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Research 1118, 176–182.
K Domschke , U Dannlowski , P Ohrmann , B Lawford , J Bauer , H Kugel , W Heindel , R Young , P Morris , V Arolt , (2008 a). Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression. European Journal of Neuropsychopharmacology 18, 751–759.
K Domschke , C Hohoff , L Mortensen , T Roehrs , J Deckert , V Arolt , B Baune (2008 b). Monoamine oxidase A variant influences antidepressant treatment response in female patients with major depression. Progress in Neuropsychopharmacology & Biological Psychiatry 32, 224–228.
M Egan , M Kojima , J Callicott , T Goldberg , B Kolachana , A Bertolino , E Zaitsev , B Gold , D Goldman , M Dean , B Lu , D Weinberger (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257–269.
M Fava , A Rush , J Alpert , G Balasubramani , S Wisniewski , C Carmin , M Biggs , S Zisook , A Leuchter , R Howland , D Warden , M Trivedi (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry 165, 342–351.
E Green N Craddock (2003). Brain-derived neurotrophic factor as a potential risk locus for bipolar disorder: evidence, limitations, and implications. Current Psychiatry Reports 5, 469–476.
C Hong , S Huo , F Yen , C Tung , G Pan , S Tsai (2003). Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48, 186–189.
R Huang , J Huang , H Cathcart , S Smith , S Poduslo (2007). Genetic variants in brain-derived neurotrophic factor associated with Alzheimer's disease. Journal of Medical Genetics 44, 66–71.
J Hwang , S Tsai , C Hong , C Yang , J Lirng , Y Yang (2006). The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiology of Aging 27, 1834–1837.
M Jansson , M Gatz , S Berg , B Johansson , B Malmberg , G McClearn , M Schalling , N Pedersen (2004). Gender differences in heritability of depressive symptoms in the elderly. Psychological Medicine 34, 471–479.
X Jiang , K Xu , J Hoberman , F Tian , AJ Marko , JF Waheed , CR Harris , AM Marini , MA Enoch , RH Lipsky (2005). BDNF variation and mood disorders: a novel functional promoter polymorphism and Val66Met are associated with anxiety but have opposing effects. Neuropsychopharmacology 30, 1353–1361.
K Kendler , M Gatz , C Gardner , N Pedersen (2006). A Swedish national twin study of lifetime major depression. American Journal of Psychiatry 163, 109–114.
U Lang , R Hellweg , P Kalus , M Bajbouj , K Lenzen , T Sander , D Kunz , J Gallinat (2005). Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology 180, 95–99.
K Martinowich , B Lu (2008). Interaction between BDNF and serotonin: role in mood disorders. Neuropsychopharmacology 33, 73–83.
FJ McMahon , S Buervenich , D Charney , R Lipsky , AJ Rush , AF Wilson , AJ Sorant , GJ Papanicolaou , G Laje , M Fava , (2006). Variation in the gene encoding the serotonin 2A receptor is associated with outcome of antidepressant treatment. American Journal of Human Genetics 78, 804–814.
J Mercader , M Ribasés , M Gratacòs , J González , M Bayés , R de Cid , A Badía , F Fernández-Aranda , X Estivill (2007). Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behavior 6, 706–716.
S Neeper , F Gomez-Pinilla , J Choi , C Cotman (1996). Physical activity increases mRA for brain-derived neurotrophic factor and nerve growth factor in rat brain. Brain Research 726, 49–56.
M Nibuya , S Morinobu , R Duman (1995). Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. Journal of Neuroscience 15, 7539–7547.
, M Beaulieu
, C Park
, D Kosman
, G del Mistro
, D van den Boom
, C Jurinke
). ‘iPLEX™ assay: increased plexing efficiency and flexibility for MassARRAY system through single base primer extension with mass-modified terminators (http://www.agrf.org.au/docstore/snp/iPlex.pdf
). Accessed 21 June 2008.
L Radloff (1977). The CES-D Scale: a self-report depression scale for research in the general population. Applied Psychological Measurement 1, 385–401.
L Ribeiro , J Busnello , R Cantor , F Whelan , P Whittaker , P Deloukas , M Wong , J Licinio (2007). The brain-derived neurotrophic factor rs6265 (Val66Met) polymorphism and depression in Mexican-Americans. Neuroreport 18, 1291–1293.
J Schumacher , R Jamra , T Becker , S Ohlraun , N Klopp , E Binder , T Schulze , M Deschner , C Schmäl , S Höfels , (2005). Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biological Psychiatry 58, 307–314.
N Seidah , S Benjannet , S Pareek , M Chrétien , R Murphy (1996). Cellular processing of the neurotrophin precursors of NT3 and BDNF by the mammalian proprotein convertases. FEBS Letters 379, 247–250.
S Sen , R Nesse , S Stoltenberg , S Li , L Gleiberman , A Chakravarti , A Weder , M Burmeister (2003). A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology 28, 397–401.
J Siuciak , D Lewis , S Wiegand , R Lindsay (1997). Antidepressant-like effect of brain-derived neurotrophic factor (BDNF). Pharmacology Biochemistry Behavior 56, 131–137.
M Ventriglia , L Bocchio Chiavetto , L Benussi , G Binetti , O Zanetti , MA Riva , M Gennarelli (2002). Association between the BDNF 196 A/G polymorphism and sporadic Alzheimer's disease. Molecular Psychiatry 7, 136–137.
M Weissman , R Bland , P Joyce , S Newman , J Wells , H Wittchen (1993). Sex differences in rates of depression: cross-national perspectives. Journal of Affective Disorder 29, 77–84.